Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    Teva Pharmaceuticals logo featuring the companys symbol with a stylized representation of a shoe and a pharmaceutical symbol

    Teva Pharmaceuticals

    Teva Pharmaceuticals is a global biopharmaceutical leader specializing in innovative medicines, generics, and biosimilars, serving patients in over 57 markets worldwide.

    Company Overview

    Teva Pharmaceuticals is a multinational pharmaceutical company focused on developing, manufacturing, and distributing both innovative and generic medicines. With a robust presence in the biopharmaceutical sector, Teva operates across 57 markets and employs approximately 37,000 people. The company is recognized for its commitment to advancing healthcare through a diverse portfolio of products and a strong global supply chain.

    Key Metrics

    12,000

    Import Shipments

    35

    Distribution Centers

    15.5B

    Annual Revenue

    1901

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Teva Pharmaceuticals is advancing its growth strategy by expanding its innovative medicines portfolio, optimizing its generics business, and investing in biopharmaceutical research and development.

    Strategic Expansion

    Launch of the “Pivot to Growth” strategy, focusing on innovation and operational efficiency

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Teva Pharmaceuticals delivers a comprehensive range of pharmaceutical products, including innovative medicines, generics, biosimilars, and over-the-counter solutions. The company’s global network ensures reliable access to essential medicines for millions of patients. Teva’s operations are supported by advanced research and development, a strong pipeline of late-stage assets, and a focus on both specialty and generic pharmaceuticals. Their strategy emphasizes sustainable growth, operational excellence, and a commitment to improving patient outcomes.

    Headquarters

    Tel Aviv, Israel

    Founded

    1901

    Stock Symbol

    TEVA